Related Experiment Video
Updated: Jul 13, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure
Serafino Fazio1, Emiliano A Palmieri, Flora Affuso
1Department of Internal Medicine, Cardiovascular and Immunological Sciences, University Federico II School of Medicine, 80131 Naples, Italy. fazio@unina.it
Insights
Growth hormone (GH) treatment significantly improved exercise capacity and cardiopulmonary function in patients with chronic heart failure (CHF). These findings suggest GH may offer a new therapeutic avenue for managing CHF patients.
Area of Science:
- Cardiology
- Endocrinology
- Exercise Physiology
Background:
- Growth hormone (GH) has shown beneficial effects in experimental heart failure models.
- Investigated GH's impact on exercise capacity and cardiopulmonary performance in dilated cardiomyopathy patients with chronic heart failure (CHF).
Purpose of the Study:
- To evaluate the effects of GH administration on physical exercise capacity and cardiopulmonary performance in patients with chronic heart failure (CHF).
Main Methods:
- A randomized, double-blind trial involving 22 CHF patients (NYHA class II-III).
- Patients received either GH (4 IU sc every other day) or placebo for 3 months.
- Spirometry and symptom-limited cardiopulmonary exercise testing were performed before and after treatment.
Main Results:
- GH treatment increased IGF-I levels and improved NYHA functional class, exercise duration, peak power output, peak oxygen consumption, and anaerobic threshold.
- GH also improved ventilatory efficiency and chronotropic index without altering lung function.
- Placebo group showed no significant improvements.
Conclusions:
- GH administration enhanced physical exercise capacity and cardiopulmonary performance in CHF patients.
- These findings provide insights into potential mechanisms of GH's benefit in CHF.
- GH may represent a novel therapeutic strategy for improving outcomes in CHF.
Background:
Because GH exerted beneficial effects in various experimental models of heart failure, we investigated the effects of GH on physical exercise capacity and cardiopulmonary performance in patients with dilated cardiomyopathy and chronic heart failure (CHF).
Methods:
Twenty-two patients with CHF (New York Heart Association functional class II-III) underwent spirometry and a symptom-limited, cardiopulmonary exercise testing before and after 3 months of GH (n = 11; seven males; seven idiopathic; 57 +/- 11 yr; 4 IU sc every other day) or placebo (n = 11; eight males; six idiopathic; 54 +/- 10 yr) administration, in a randomized, double-blind trial. Background CHF therapy remained unchanged.
Results:
GH, but not placebo, increased IGF-I serum concentration (from 144 +/- 35 to 293 +/- 58 ng/ml; P < 0.005) and improved New York Heart Association functional class (from 2.4 +/- 0.5 to 1.8 +/- 0.4; P < 0.005), exercise duration (from 831 +/- 273 to 925 +/- 266 sec; P < 0.005), peak power output (from 245 +/- 127 to 280 +/- 132 W; P < 0.05), peak minute ventilation (from 52.5 +/- 16.1 to 61.3 +/- 17.3 liters/min; P < 0.05), peak oxygen consumption (from 19.8 +/- 5.6 to 25.1 +/- 5.6 ml/kg.min; P < 0.005), and anaerobic threshold (from 14.9 +/- 4.8 to 20.0 +/- 4.5 ml/kg.min; P < 0.005) without affecting lung function parameters. Furthermore, the slope of the relationship between minute ventilation and pulmonary carbon dioxide production (ventilatory efficiency) decreased from 34.7 +/- 5.1 to 31.7 +/- 5.3 (P < 0.005), whereas the slope of the relation between percent predicted heart rate reserve used and percent observed metabolic reserve used (chronotropic index) rose from 0.57 +/- 0.20 to 0.69 +/- 0.18 (P < 0.005).
Conclusion:
Given the predictive value of physical exercise capacity and cardiopulmonary performance in CHF progression, these data provide additional insights into the mechanisms by which GH may potentially benefit CHF patients.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
